Insiders VACY AS Oslo Bors

Equities

VACC

NO0010714785

End-of-day quote Oslo Bors Other stock markets			5-day change	1st Jan Change
- ^PTS	-.--%		-.--%	-.--%

14/05	Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024
14/05	Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nykode Therapeutics AS Announces Management Changes	11/23/11	CI
Nykode Therapeutics : Nomination Committee Proposal	20/23/20	PU
Nykode Therapeutics Names CureVac Exec As New Chief Development Officer	13/22/13	MT
Nykode Therapeutics AS Appoints Klaus Edvardsen as Chief Development Officer, Effective from July 1, 2022	13/22/13	CI
Nykode Therapeutics AS Appoints Elaine Sullivan and Anne Whitaker to the Board of Directors	12/22/12	CI
Nykode Therapeutics Names New Chair	15/21/15	MT
Vaccibody to Change Name to Nykode Therapeutics	23/21/23	MT
Vaccibody AS has Changed its Name to Nykode Therapeutics	23/21/23	CI
Vaccibody AS Announces Management Appointments, Effective June 1, 2021	12/21/12	CI
Vaccibody AS Appoints Dr. Volck as New Member of the Board	05/21/05	CI
Vaccibody AS Appoints Harald Gurvin as New Chief Financial Officer, Effective May 3, 2021	28/21/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer